Genprex, Inc. 2DE.F Stock
Genprex, Inc. Price Chart
Genprex, Inc. 2DE.F Financial and Trading Overview
| Genprex, Inc. stock price | 0.16 EUR |
| Previous Close | 0.76 EUR |
| Open | 0.75 EUR |
| Bid | 0.76 EUR x 0 |
| Ask | 0.79 EUR x 0 |
| Day's Range | 0.75 - 0.75 EUR |
| 52 Week Range | 0.67 - 2.31 EUR |
| Volume | 150 EUR |
| Avg. Volume | 287 EUR |
| Market Cap | 39.17M EUR |
| Beta (5Y Monthly) | -0.322887 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 8 EUR |
2DE.F Valuation Measures
| Enterprise Value | 21.53M EUR |
| Trailing P/E | N/A |
| Forward P/E | -1.507 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 2.1165729 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.775 |
Trading Information
Genprex, Inc. Stock Price History
| Beta (5Y Monthly) | -0.322887 |
| 52-Week Change | -34.59% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2.31 EUR |
| 52 Week Low | 0.67 EUR |
| 50-Day Moving Average | 0.78 EUR |
| 200-Day Moving Average | 1.25 EUR |
2DE.F Share Statistics
| Avg. Volume (3 month) | 287 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 51.98M |
| Float | 51.18M |
| Short Ratio | N/A |
| % Held by Insiders | 4.50% |
| % Held by Institutions | 7.79% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -55.37% |
| Return on Equity (ttm) | -99.56% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -27768408 EUR |
| Net Income Avi to Common (ttm) | -27633578 EUR |
| Diluted EPS (ttm) | -0.53 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 18.08M EUR |
| Total Cash Per Share (mrq) | 0.35 EUR |
| Total Debt (mrq) | 0 EUR |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 4.124 |
| Book Value Per Share (mrq) | 0.356 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -20639704 EUR |
| Levered Free Cash Flow (ttm) | -10521287 EUR |
Profile of Genprex, Inc.
| Country | Germany |
| State | TX |
| City | Austin |
| Address | 3300 Bee Cave Road |
| ZIP | 78746 |
| Phone | (877) 774-4679 |
| Website | https://www.genprex.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 28 |
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) that is in Phase 1/2 and 2 clinical trials to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002 for the treatment of type 1 diabetes, and GPX-003 for the treatment of type 2 diabetes. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas.
Q&A For Genprex, Inc. Stock
What is a current 2DE.F stock price?
Genprex, Inc. 2DE.F stock price today per share is 0.16 EUR.
How to purchase Genprex, Inc. stock?
You can buy 2DE.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Genprex, Inc.?
The stock symbol or ticker of Genprex, Inc. is 2DE.F.
Which industry does the Genprex, Inc. company belong to?
The Genprex, Inc. industry is Biotechnology.
How many shares does Genprex, Inc. have in circulation?
The max supply of Genprex, Inc. shares is 1.49M.
What is Genprex, Inc. Price to Earnings Ratio (PE Ratio)?
Genprex, Inc. PE Ratio is 0.00000000 now.
What was Genprex, Inc. earnings per share over the trailing 12 months (TTM)?
Genprex, Inc. EPS is 0 EUR over the trailing 12 months.
Which sector does the Genprex, Inc. company belong to?
The Genprex, Inc. sector is Healthcare.